Calcibind and Insulin glargine and lixisenatide
Determining the interaction of Calcibind and Insulin glargine and lixisenatide and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: cellulose sodium phosphate
Brand name:
Synonyms: Calcibind (Oral)
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Calcibind-Insulin glargine and lixisenatide Subcutaneous
- Calcibind-Insulin glargine, recombinant Subcutaneous
- Calcibind-Insulin glulisine
- Calcibind-Insulin Glulisine (Cartridges and Pens)
- Calcibind-Insulin Glulisine (Vials)
- Calcibind-Insulin glulisine Subcutaneous
- Insulin glargine and lixisenatide-Calcidol
- Insulin glargine and lixisenatide-Calcifediol
- Insulin glargine and lixisenatide-Calciferol
- Insulin glargine and lixisenatide-CalciFol
- Insulin glargine and lixisenatide-CalciFolic-D (Calcium Carbonate/Vit D/Vit B6/Vit B12/Folic Acid with Minerals Chew Wafers)
- Insulin glargine and lixisenatide-CalciFolic-D (Vitamins (Multiple/Oral))